Skip to Primary Navigation

Skip to main content

New York attorney general charges former Emergent BioSolutions chief with insider trading

Photo of New York State Attorney General Letitia James standing in front of the seal of the Office of the Attorney General with a blue background.
Photo: Michael M. Santiago/Getty Images

Kevin Kinsella

1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Robert G Kramer is accused of selling his company shares before publicly revealing contamination issues with his company’s COVID-19 vaccine production.

The Office of the New York Attorney General (OAG) has announced it is suing former Emergent BioSolutions CEO Robert Kramer for insider trading.

The OAG also announced a settlement with Emergent for approving Kramer’s illegal trading plan.

In the summer of 2020, Emergent, which contracts with pharmaceutical

Following

, , , , , ,